Drug delivery researchers have vastly improved the potential of genetic therapies by overcoming the challenge of consistently getting genes and gene-editing tools where they need to be within cells.

Statistics that quantify a person’s predisposition to diseases such as diabetes and cancer can be reverse-engineered to reveal the underlying genetic data, prompting privacy concerns ...